TY - JOUR
T1 - Distribution and characteristics of Escherichia coli clonal group A
AU - Johnson, James R.
AU - Murray, Andrew C.
AU - Kuskowski, Michael A.
AU - Schubert, Sören
AU - Prère, Marie Francoise
AU - Picard, Bertrand
AU - Colodner, Raul
AU - Raz, Raul
AU - Bodison, Sacared
AU - Cockerill, Franklin R.
AU - Da Cunha, Clovis Arns
AU - Echeverria, Peter
AU - Simasathien, Sriluck
AU - Gaastra, Wim
AU - Hall, Lucinda M.C.
AU - Klein, Marina
AU - Lockman, Hank A.
AU - Omer, Imad
AU - Schwebke, Jane R.
AU - Prats, Guillem
AU - Rakita, Robert M.
AU - Rossman, Susan
AU - Schifman, Ronald
AU - Smith, Ronald
AU - Winokur, Patricia L.
PY - 2005/1
Y1 - 2005/1
N2 - Among 1,102 recent Escherichia coli clinical isolates, clonal group A was identified in 17 of 20 (U.S. and non-U.S.) geographic locales, mainly among U.S. isolates (9% vs. 3%; p < 0.001) and those resistant to trimethoprim- sulfamethoxazole (10% vs. 1.7%; p < 0.001). The extensive antimicrobial resistance and virulence profiles of clonal group A may underlie its recent widespread emergence.
AB - Among 1,102 recent Escherichia coli clinical isolates, clonal group A was identified in 17 of 20 (U.S. and non-U.S.) geographic locales, mainly among U.S. isolates (9% vs. 3%; p < 0.001) and those resistant to trimethoprim- sulfamethoxazole (10% vs. 1.7%; p < 0.001). The extensive antimicrobial resistance and virulence profiles of clonal group A may underlie its recent widespread emergence.
UR - http://www.scopus.com/inward/record.url?scp=19944427996&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=19944427996&partnerID=8YFLogxK
U2 - 10.3201/eid1101.040418
DO - 10.3201/eid1101.040418
M3 - Article
C2 - 15705341
AN - SCOPUS:19944427996
SN - 1080-6040
VL - 11
SP - 141
EP - 145
JO - Emerging infectious diseases
JF - Emerging infectious diseases
IS - 1
ER -